Evolving utility of sex hormone-binding globulin measurements in clinical medicine

Current Opinion in Endocrinology, Diabetes and Obesity

Volumn 19, Issue 3, 2012, Pages 183-189

  Hammond, Geoffrey L ^a   Wu, Tsung Sheng ^a   Simard, Marc ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

androgen excess; estradiol; metabolic syndrome; testosterone; thyroid disease

Indexed keywords

SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

BLOOD LEVEL; CARDIOVASCULAR DISEASE; CLINICAL MEDICINE; ENDOCRINE DISEASE; GENETIC POLYMORPHISM; HORMONAL REGULATION; HORMONE DETERMINATION; HUMAN; METABOLIC DISORDER; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; REVIEW; TESTOSTERONE BLOOD LEVEL;

BIOLOGICAL MARKERS; ESTRADIOL; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; SEX DISTRIBUTION; SEX HORMONE-BINDING GLOBULIN; TESTOSTERONE;

EID: 84860741362     PISSN: 1752296X     EISSN: 17522978     Source Type: Journal    
DOI: 10.1097/MED.0b013e328353732f     Document Type: Review

References (52)

1. Hammond GL. Diverse roles for sex hormone-binding globulin in reproduction. Biol Reprod 2011; 85:431-441.
2. Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 1999; 84:3666-3672. (Pubitemid 30645223)
3. Hammond GL. Access of reproductive steroids to target tissues. Obstet Gynecol Clin North Am 2002; 29:411-423.
4. Dunn JF, Nisula BC, Rodbard D. Transport of steroid hormones: binding of 21 endogenous steroids to both testosterone-binding globulin and corticosteroid-binding globulin in human plasma. J Clin Endocrinol Metab 1981; 53:58-68. (Pubitemid 13245381)
5. Avvakumov GV, Cherkasov A, Muller YA, Hammond GL. Structural analyses of sex hormone-binding globulin reveal novel ligands and function. Mol Cell Endocrinol 2010; 316:13-23.
6. Ohlsson C, Wallaschofski H, Lunetta KL, et al. Genetic determinants of serum testosterone concentrations in men. PLoS Genet 2011; 7:e1002313.
7. Cousin P, Dechaud H, Grenot C, et al. Influence of glycosylation on the clearance of recombinant human sex hormone-binding globulin from rabbit blood. J Steroid Biochem Mol Biol 1999; 70:115-121. (Pubitemid 29528421)
8. Ng KM, Catalano MG, Pinos T, et al. Evidence that fibulin family members contribute to the steroid-dependent extravascular sequestration of sex hormone-binding globulin. J Biol Chem 2006; 281:15853-15861. (Pubitemid 43848476)
9. Avvakumov GV, Grishkovskaya I, Muller YA, Hammond GL. Resolution of the human sex hormone-binding globulin dimer interface and evidence for two steroid-binding sites per homodimer. J Biol Chem 2001; 276:34453-34457.
10. Sartorius G, Ly LP, Sikaris K, et al. Predictive accuracy and sources of variability in calculated free testosterone estimates. Ann Clin Biochem 2009; 46:137-143.
11. Hogeveen KN, Cousin P, Pugeat M, et al. Human sex hormone-binding globulin variants associated with hyperandrogenism and ovarian dysfunction. J Clin Invest 2002; 109:973-981. (Pubitemid 34275118)
12. Leger J, Forest MG, Czernichow P. Thyroid hormones influences sex steroid binding protein levels in infancy: study in congenital hypothyroidism. J Clin Endocrinol Metab 1990; 71:1147-1150.
13. Sorensen K, Andersson AM, Skakkebaek NE, Juul A. Serum sex hormonebinding globulin levels in healthy children and girls with precocious puberty before and during gonadotropin-releasing hormone agonist treatment. J Clin Endocrinol Metab 2007; 92:3189-3196. (Pubitemid 47236390)
14. Elmlinger MW, Kuhnel W, Wormstall H, Doller PC. Reference intervals for testosterone, androstenedione and SHBG levels in healthy females and males from birth until old age. Clin Lab 2005; 51:625-632. (Pubitemid 41763079)
15. Burger HG, Dudley EC, Cui J, et al. A prospective longitudinal study of serum testosterone, dehydroepiandrosterone sulfate, and sex hormone-binding globulin levels through the menopause transition. J Clin Endocrinol Metab 2000; 85:2832-2838. (Pubitemid 32269161)
16. Pasquali R. Obesity, fat distribution and infertility. Maturitas 2006; 54:363-371.
17. Azrad M, Gower BA, Hunter GR, Nagy TR. Intra-abdominal adipose tissue is independently associated with sex-hormone binding globulin in premenopausal women. Obesity (Silver Spring) 2012. doi: 10.1038/oby.2011.375. [Epub ahead of print].
18. Janne M, Hammond GL. Hepatocyte nuclear factor-4 controls transcription from a TATA-less human sex hormone-binding globulin gene promoter. J Biol Chem 1998; 273:34105-34114. (Pubitemid 29008880)
19. Selva DM, Hammond GL. Thyroid hormones act indirectly to increase sex hormone-binding globulin production by liver via hepatocyte nuclear factor-4alpha. J Mol Endocrinol 2009; 43:19-27.
20. Carlstrom K, Eriksson S, Rannevik G. Sex steroids and steroid binding proteins in female alcoholic liver disease. Acta Endocrinol (Copenh) 1986; 111:75-79. (Pubitemid 16187049)
21. Bulman MP, Dronsfield MJ, Frayling T, et al. A missense mutation in the hepatocyte nuclear factor 4 alpha gene in a UK pedigree with maturity-onset diabetes of the young. Diabetologia 1997; 40:859-862. (Pubitemid 27306966)
22. Bhasin S, Jasjua GK, Pencina M, et al. Sex hormone-binding globulin, but not testosterone, is associated prospectively and independently with incident metabolic syndrome in men: the Framingham heart study. Diabetes Care 2011; 34:2464-2470.
23. Le TN, Nestler JE, Strauss JF, Wickham EP. Sex hormone-binding globulin and type 2 diabetes mellitus. Trends Endocrinol Metab 2012; 23:32-40.
24. Haffner SM, Katz MS, Stern MP, Dunn JF. Association of decreased sex hormone binding globulin and cardiovascular risk factors. Arteriosclerosis 1989; 9:136-143. (Pubitemid 19046100)
25. Selva DM, Hammond GL. Peroxisome-proliferator receptor gamma represses hepatic sex hormone-binding globulin expression. Endocrinology 2009; 150:2183-2189.
26. Dunaif A, Scott D, Finegood D, et al. The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome. J Clin Endocrinol Metab 1996; 81:3299-3306. (Pubitemid 26296206)
27. Hammond GL, Lahteenmaki PL. A versatile method for the determination of serum cortisol binding globulin and sex hormone binding globulin binding capacities. Clin Chim Acta 1983; 132:101-110. (Pubitemid 13069702)
28. Goodarzi MO, Dumesic DA, Chazenbalk G, Azziz R. Polycystic ovary syndrome: etiology, pathogenesis and diagnosis. Nat Rev Endocrinol 2011; 7:219-231.
29. Simo R, Barbosa-Desongles A, Lecube A, et al. Potential role of tumor necrosis factor-alpha in downregulating sex hormone-binding globulin. Diabetes 2012; 61:372-382.
30. Garcia JM, Li H, Mann D, et al. Hypogonadism in male patients with cancer. Cancer 2006; 106:2583-2591.
31. Krassas GE, Poppe K, Glinoer D. Thyroid function and human reproductive health. Endocr Rev 2010; 31:702-755.
32. Krause A, Sinnecker GH, Hiort O, et al. Applicability of the SHBG androgen sensitivity test in the differential diagnosis of 46,XY gonadal dysgenesis, true hermaphroditism, and androgen insensitivity syndrome. Exp Clin Endocrinol Diabetes 2004; 112:236-240. (Pubitemid 38679267)
33. Handelsman DJ, Conway AJ, Boylan LM. Pharmacokinetics and pharmacodynamics of testosterone pellets in man. J Clin Endocrinol Metab 1990; 71:216-222.
34. Wang C, Cunningham G, Dobs A, et al. Long-term testosterone gel (Andro-Gel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men. J Clin Endocrinol Metab 2004; 89:2085-2098. (Pubitemid 38619836)
35. Carlstrom K, Eriksson A, Gustafsson SA, et al. Influence of orchidectomy or oestrogen treatment on serum levels of pregnancy associated alpha 2-glycoprotein and sex hormone binding globulin in patients with prostatic cancer. Int J Androl 1985; 8:21-27. (Pubitemid 15112230)
36. Stone J, Folkerd E, Doody D, et al. Familial correlations in postmenopausal serum concentrations of sex steroid hormones and other mitogens: a twins and sisters study. J Clin Endocrinol Metab 2009; 94:4793-4800.
37. Cousin P, Calemard-Michel L, Lejeune H, et al. Influence of SHBG gene pentanucleotide TAAAA repeat and D327N polymorphism on serum sex hormone-binding globulin concentration in hirsute women. J Clin Endocrinol Metab 2004; 89:917-924. (Pubitemid 38269911)
38. Eriksson AL, Lorentzon M, Mellstrom D, et al. SHBG gene promoter polymorphisms in men are associated with serum sex hormone-binding globulin, androgen and androgen metabolite levels, and hip bone mineral density. J Clin Endocrinol Metab 2006; 91:5029-5037. (Pubitemid 44917346)
39. Ding EL, Song Y, Manson JE, et al. Sex hormone-binding globulin and risk of type 2 diabetes in women and men. N Engl J Med 2009; 361:1152-1163.
40. Power SG, Bocchinfuso WP, Pallesen M, et al. Molecular analyses of a human sex hormone-binding globulin variant: evidence for an additional carbohydrate chain. J Clin Endocrinol Metab 1992; 75:1066-1070.
41. Zhang B, Beeghly-Fadiel A, Lu W, et al. Evaluation of functional genetic variants for breast cancer risk: results from the Shanghai breast cancer study. Am J Epidemiol 2011; 173:1159-1170.
42. Xu WH, Zheng W, Cai Q, et al. The Asp(327)Asn polymorphism in the sex hormone-binding globulin gene modifies the association of soy food and tea intake with endometrial cancer risk. Nutr Cancer 2008; 60:736-743.
43. Hogeveen KN, Talikka M, Hammond GL. Human sex hormone-binding globulin promoter activity is influenced by a (TAAAA)n repeat element within an Alu sequence. J Biol Chem 2001; 276:36383-36390.
44. Xita N, Tsatsoulis A. Genetic variants of sex-hormone binding globulin and their biological consequences. Mol Cell Endocrinol 2010; 316:60-65.
45. Haiman CA, Riley SE, Freedman ML, Setiawan VW, et al. Common genetic variation in the sex steroid hormone-binding globulin (SHBG) gene and circulating SHBG levels among postmenopausal women: the Multiethnic Cohort. J Clin Endocrinol Metab 2005; 90:2198-2204. (Pubitemid 40586262)
46. Saltiki K, Stamatelopoulos K, Voidonikola P, et al. Association of the SHBG gene promoter polymorphism with early markers of atherosclerosis in apparently healthy women. Atherosclerosis 2011; 219:205-210.
47. Thompson DJ, Healey CS, Baynes C, et al. Identification of common variants in the SHBG gene affecting sex hormone-binding globulin levels and breast cancer risk in postmenopausal women. Cancer Epidemiol Biomarkers Prev 2008; 17:3490-3498.
48. Perry JR, Weedon MN, Langenberg C, et al. Genetic evidence that raised sex hormone binding globulin (SHBG) levels reduce the risk of type 2 diabetes. Hum Mol Genet 2010; 19:535-544.
49. Lee IW, Kuo PH, Su MT, Kuan LC, et al. Quantitative trait analysis suggests polymorphisms of estrogen-related genes regulate human sperm concentrations and motility. Hum Reprod 2011; 26:1585-1596.
50. Costantino L, Catalano MG, Frairia R, Carmazzi C, et al. Molecular mechanisms of the D327N SHBG protective role on breast cancer development after estrogen exposure. Breast Cancer Res Treat 2009; 114:449-456.
51. Friedman JR, Kaestner KH. The Foxa family of transcription factors in development and metabolism. Cell Mol Life Sci 2006; 63:2317-2328. (Pubitemid 44653042)
52. Mousavinasab F, Tahtinen T, Jokelainen J, et al. The Pro12Ala polymorphism of the PPAR gamma 2 gene influences sex hormone-binding globulin level and its relationship to the development of the metabolic syndrome in young Finnish men. Endocrine 2006; 30:185-190. (Pubitemid 46340519)